期刊文献+

GM-CSF/IL1-5融合基因原核表达载体的构建及表达

Clone and Expression of A Recombinant Vector for GM-CSF/IL-15 Fusion Gene
在线阅读 下载PDF
导出
摘要 目的构建原核表达质粒pPROEXTMHTbGMCSF/IL15并在大肠杆菌DH5α中表达,以期获得具有GMCSF/IL15双重活性的融合蛋白。方法利用分子生物工程技术,构建重组原核表达载体pPROEXTMHTbGM15,并转化进大肠杆菌DH5αIPTG诱导表达4h后,经SDSPAGE、免疫印迹证实为GM15融合蛋白。结果重组载体经转化大肠杆菌DH5α后,诱导表达出相对分子质量约为33kD左右的融合蛋白。结论构建了pPROEXTMHTbGMCSF/IL15融合基因表达系统,并诱导表达出GM15融合蛋白。 Objective Construct pPROEXTM HTb-GM-CSF/IL-15 and express in DH5α to obtain the GM-15 fusion protein, which may have double activity. Methods Using molecular biological techniques, a recombinant vector pPROEXTMHTb-GM-CSF/IL-15 was constructed, and express fusion protein inducing by IPTG 4 h. The fusion protein was vetified by SDS-PAGE, Western blot. Results The fusion protein with relative molecular mass of 33 kD was yielded in DH5α by induced. If possessed double activity of anti GM-CSF and anti IL-15 by western blot assay. Conclusion The successful construction of the expression vector laid a foundation of largly product and clinical use of the fusion protein.
出处 《福建医科大学学报》 2006年第2期111-113,共3页 Journal of Fujian Medical University
基金 福建省卫生厅医学创新基金资助项目(2001CX12)
关键词 GM—CSF 白细胞介素15 重组融合蛋白质类 质粒 基因表达 granulocyte-macrophoge colong-stimulating factor interleukin-15 recombinant fusion protein plasmids gene expression
  • 相关文献

参考文献5

二级参考文献14

  • 1Nakazaki Y,Tani K,Lin ZT,et al. Vaccine effect of granulocyte-macrophage colony-stimulating factor or CD80 gene-transduced murine hematopoietic tumor cells and their cooperative enhancement of antitumor immunity[J]. Gene Ther, 1998,5(10):1355-1362.
  • 2Stripecke R,Skelton DC,Pattengale PK,et al.Combination of CD80 and granulocyte-macrophage colony-stimulating factor coexpression by a leukemia cell vaccine:preclinical studies in a murine model recapitulating Philadelphia chromosome-positive acute lymphoblastic leukemia[J].Hum Gene Ther,1999,10(13):2109-2122.
  • 3Stripecke R, Cardoso AA,Pepper KA,et al. Lentiviral vectors for efficient delivery of CD80 and granuiocyte-macrophagecoiony-stimulating factor in human acute iymphoblastic leukemia and acute myeloid leukcmia cells to induce antileukemic immune responses [J]. Blood, 2000, 96 (4) : 1317-1326.
  • 4Koya RC,Kasahara N,Pullarkat V,et al.Transduction of actue myeloid leukemia cells with third generation self-inactivating lentiviral vectors expressing CD80 and GM-CSF:effects on proliferation,differentiation,and stinaulation of allogeneic and autologous anti-leukemia immune responses[J].Leukemia,2002,16(10):1645-1654.
  • 5Gaken J, Jing J, Daniel K, et al. Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron[J]. Gene Ther, 2000,7(23):1979-1985.
  • 6Chen B, Timiryasova TM, Haghighat P, et al. Low-dose vaccinia virus-mediated cytokine gene therapy of glioma. J Immunother,2001, 24:46-57.
  • 7Gillies SD, Lan Y, Brunkhorst B, et al. Bi-functional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer. Cancer Immunol Immunother, 2002, 51:449-460.
  • 8Dietrich A, Kraus K, Brinckmann U, et al. Complex cancer gene therapy in mice melanoma. Langenbecks Arch Surg, 2002, 387:177-182.
  • 9Li D, Shugert E, Guo M, et al. Combination nonviral interleukin 2 and interleukin 12 gene therapy for head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg, 2001, 127: 1319-1324.
  • 10Wigginton JM, Wiltrout RH. IL-12/IL-2 combination cytokine therapy for solid tumours: translation from bench to bedside. Expert Opin Biol Ther, 2002, 2:513-524.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部